ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of January

January 31, 2014

In Brief: Hong, Posner Awarded ACS Research Professorships; Hawaii Wins Center Grants

July 26, 1996

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

In Brief: Foundation Gives Georgetown $2.9 Million For Pediatric Lab, To Be Headed By Cairo

February 6, 1998

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

NCI-Approved Clinical Trials Listed For January

January 28, 2005